HIF1A and cancer: Under hypoxia conditions, PHD activity is impaired, and the formation of the complex (VCB-CR) is prevented, recognition of HIF-1α is impaired, HIF-1α is stabilized, and a hyperglycolytic phenotype is generated in cancer cells [20].